Literature DB >> 1886783

A simple method for introducing a thiol group at the 5'-end of synthetic oligonucleotides.

A Kumar1, S Advani, H Dawar, G P Talwar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1886783      PMCID： PMC328658          DOI： 10.1093/nar/19.16.4561

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  5 in total

1.  The preparation and application of functionalised synthetic oligonucleotides: III. Use of H-phosphonate derivatives of protected amino-hexanol and mercapto-propanol or -hexanol.

Authors:  N D Sinha; R M Cook
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

2.  N-(1-pyrene)maleimide: a fluorescent cross-linking reagent.

Authors:  C W Wu; L R Yarbrough
Journal:  Biochemistry       Date:  1976-06-29       Impact factor: 3.162

3.  A simple method for the introduction of thiol group at 5'-termini of oligodeoxynucleotides.

Authors:  R K Gaur; P Sharma; K C Gupta
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

4.  A new method for the selective isolation of cysteine-containing peptides. Specific labelling of the thiol group with a hydrophobic chromophore.

Authors:  J Y Chang; R Knecht; D G Braun
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

5.  Chemical synthesis of oligonucleotides containing a free sulphydryl group and subsequent attachment of thiol specific probes.

Authors:  B A Connolly; P Rider
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971
  5 in total
  2 in total

1.  Characterization and sequence verification of thiolated deoxyoligonucleotides used for microarray construction.

Authors:  Arthur Van Aerschot; Jef Rozenski
Journal:  J Am Soc Mass Spectrom       Date:  2006-08-08       Impact factor: 3.109

Review 2.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Authors:  Nicolas Bertrand; Jun Wu; Xiaoyang Xu; Nazila Kamaly; Omid C Farokhzad
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.